We did observe a 14% decreased risk of skin cancer among patients exposed to nicotinamide compared to the unexposed group. Interestingly, the benefit was greatest among those who started nicotinamide after only one skin cancer, while there was a steady decay of effect with each subsequent skin cancer prior to nicotinamide initiation such that after 7 skin cancers, we no longer observed any effect.
